Aaron Ring

Director at Stipple Bio.

Raised on Stipple Bio filings

$65.1M

of $100.2M offered across 1 Form D filing

Form D filings: 1
Teammates: 6
Last filing: Apr 6, 2026

Company

Biotech · Cambridge, MA

Cancer drugs aimed at tumor-specific cell surface markers

Cancer drugs aimed at tumor-specific cell surface markers

Investors: 15
Founded: 2021
Still open: $35.1M

Investors: 15
Sector: Biotech
Founded: 2021
HQ: Cambridge, MA

Stipple Bio filings

Stipple Bio Form D filings
Filed	Security	Sold of offered	Filing
Apr 6, 2026	Equity	$65.1M/ $100.2M	Form D

EquityFiled Apr 6, 2026Form D
$65.1M/ $100.2M

Works with

Also named on Stipple Bio filings

Jeffrey LandauChief Executive Officer, Form D signerForm D signer Thilo SchroederDirector Derek DiRoccoDirector Greg VerdineDirector Owen HughesDirector Vineeta AgarwalaDirector